The Role of a Mentor: Paying It Forward

December 6th, 2016|Blog|

As a young girl growing up in Trinidad, it was easy to fall through the cracks. At a time when boys were encouraged to pursue science and girls were politely pushed in other directions, I could have easily missed out [...]

Amyris and IDRI Announce Agreement to Explore Testing and Development of Amyris Materials for Use in Vaccine Adjuvant Formulations

September 9th, 2015|Press Releases|

EMERYVILLE, Calif. and SEATTLE, Wash. (September 9, 2015) Amyris, Inc. (Nasdaq:AMRS), the industrial bioscience company, and IDRI (Infectious Disease Research Institute), a Seattle-based non-profit research organization that uses biotechnology to create new diagnostics, drugs and vaccines, today announced an [...]

AERAS and IDRI Sign Agreement to Jointly Develop Novel Tuberculosis Vaccine

May 9th, 2012|Press Releases|

Rockville, MD | Seattle, WA | May 9, 2012 Aeras and the Infectious Disease Research Institute (IDRI) announce today a new agreement to conduct joint development activities with respect to IDRI’s novel tuberculosis vaccine candidate. This collaboration reflects the [...]

IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests

August 31st, 2009|Press Releases|

Seattle, WA | Nes Ziona, Israel | August 31, 2009 The Infectious Disease Research Institute (IDRI) and NanoPass Technologies Ltd. (NanoPass) today announced they have entered into an agreement whereby IDRI licenses NanoPassʼ proprietary MicronJet microneedle technology for the [...]

Load More